NCT03456557View on ClinicalTrials.gov

The Use of Perfusion CT Derived Parameters as Early Acute Pancreatitis Severity Biomarker Compared to Clinico Biological Score

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

December 9, 2018

Study Completion Date

December 9, 2018

Conditions
Acute Pancreatitis
Interventions
RADIATION

Perfusion computed tomography.

Using specific post treatment imaging software ( Olea® ) we will calculatell permeability parameters : the pancreatic blood flow and the k-trans, capillary membrane permeability factor.

Trial Locations (1)

86021

Chu de Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT03456557 - The Use of Perfusion CT Derived Parameters as Early Acute Pancreatitis Severity Biomarker Compared to Clinico Biological Score | Biotech Hunter | Biotech Hunter